[1] World Health Organization.Global Tuberculosis Report 2019. Geneva:WHO,2019. [2] HMAMA Z, PENA-DIAZ S, JOSEPH S, et al.Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis[J]. Immunol Rev, 2015,264(1):220-232. [3] BRADFUTE S B, CASTILLO E F, ARKO-MENSAH J, et al.Autophagy as an immune effector against tuberculosis[J]. Curr Opin Microbiol, 2013,16(3):355-365. [4] BEHAR S M, MARTIN C J, BOOTY M G, et al.Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis[J]. Mucosal Immunol, 2011,4(3):279-287. [5] CARLETON M, CLEARY M A, LINSLEY P S.MicroRNAs and cell cycle regulation[J]. Cell Cycle, 2007,6(17):2127-2132. [6] QI Y, CUI L, GE Y, et al.Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection[J]. BMC Infectious Diseases, 2012, 12(1):384. [7] ZHANG G, LIU X, WANG W, et al.Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages[J]. Cell Cycle, 2016,15(18):2527-2538. [8] 杨倩婷,尤信信,陈骑,等.IP-10在结核病患者中的表达及在诊断中的应用[J/CD].新发传染病电子杂志,2017,2(4):198-201. [9] 谢舒枝,盛星,陈骑,等.趋化因子CXCL9在结核病患者血浆中的表达及临床意义[J/CD].新发传染病电子杂志,2017,2(2):93-95. [10] PHILIPPE L, ALSALEH G, PICHOT A, et al.MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytes[J]. Ann Rheum Dis, 2013,72(6):1071-1079. [11] CARLSEN A L, SCHETTER A J, NIELSEN C T, et al.Circulating microRNA expression profiles associated with systemic lupus erythematosus[J]. Arthritis Rheum, 2013,65(5):1324-1334. [12] BATTISTELLA M, ROMERO M, CASTRO-VEGA L J, et al. The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression[J]. J Invest Dermatol, 2015,135(6):1659-1667. [13] ZHAO S, YAO D, CHEN J, et al.MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo[J]. PLoS One, 2015,10(3):e120905. [14] CONZE D, KRAHL T, KENNEDY N, et al.c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation[J]. J Exp Med, 2002,195(7):811-823. [15] ZHANG E, FENG X, LIU F, et al.Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1alpha, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells[J]. PLoS One, 2014,9(7):e103440. [16] CUI J, ZHANG M, ZHANG Y Q, et al.JNK pathway: diseases and therapeutic potential[J]. Acta Pharmacol Sin, 2007,28(5):601-608. [17] 凌彦博, 梁艳, 王小美,等. 中药复方牛贝消核提取物治疗结核病相关靶标的研究[J]. 中国防痨杂志, 2016, 38(1):17-22. [18] GEISSLER A, HAUN F, FRANK D O, et al.Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK[J]. Cell Death Differ, 2013,20(10):1317-1329. |